Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 9,469,689

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,469,689
Title:Therapeutic DLL4 binding proteins
Abstract: DLL4 binding proteins are described herein, including antibodies, CDR-grafted antibodies, humanized antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 and/or VEGF activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis.
Inventor(s): Chen; Ming-Jiu (Shrewsbury, MA), Hsieh; Chung-Ming (Newton, MA), Gu; Jijie (Shrewsbury, MA), Morgan-Lappe; Susan E. (Riverwoods, IL), Li; Yingchun (Buffalo Grove, IL)
Assignee: AbbVie Inc. (North Chicago, IL)
Application Number:14/798,849
Patent Claims:see list of patent claims

Details for Patent 9,469,689

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Regeneron Pharmaceuticals, Inc. EYLEA aflibercept Injection 125387 2011-11-18 ⤷  Try it Free 2030-03-02
Regeneron Pharmaceuticals, Inc. EYLEA aflibercept Injection 125387 2018-08-16 ⤷  Try it Free 2030-03-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.